Microvision (NASDAQ:MVIS – Get Free Report)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research note issued on Tuesday,Benzinga reports. They currently have a $3.00 price objective on the electronics maker’s stock. D. Boral Capital’s price objective would suggest a potential upside of 230.76% from the stock’s previous […]

Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a note issued to investors on Tuesday,Benzinga reports. They presently have a $10.00 price objective on the medical research company’s stock. Other analysts also recently issued reports about the company. Weiss Ratings reissued a “sell (e+)” […]